DUBLIN–(BUSINESS WIRE)–The “In-Vitro Colorectal Cancer Screening Tests – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global In-Vitro Colorectal Cancer Screening Tests Market to Reach $1.1 Billion by 2030
In the changed post COVID-19 business landscape, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$853.8 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2022-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$881.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biomarker Test segment is readjusted to a revised 1.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $232.6 Million, While China is Forecast to Grow at 6.3% CAGR
The In-Vitro Colorectal Cancer Screening Tests market in the U.S. is estimated at US$232.6 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$233.4 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$149.5 Million by the year 2030.
Select Competitors (Total 44 Featured) –
Abbott Laboratories, Inc.
Alere, Inc.
Beckman Coulter, Inc.
Clinical Genomics Technologies Pty Ltd.
Eiken Chemical Co., Ltd.
Epigenomics AG
Exact Sciences Corporation
Hemosure, Inc.
Novigenix SA
Quidel Corporation
Sysmex Corporation
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
In-Vitro Colorectal Cancer Screening Tests – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Colorectal Cancer: Symptoms, Causes & Risk Factors
Screening for Colorectal Cancer
In-Vitro Colorectal Cancer Screening Tests
Fecal Occult Blood Test
Biomarker Test
CRC DNA Screening Test
Global Market Prospects & Outlook
Fecal Occult Blood Tests Dominate Market
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Colorectal Cancer Drives Market Growth
Number of New Cancer Cases and Number of Deaths by Type of Cancer in 2020
Countries with Highest Rate of Colorectal Cancer: Age-Standardized Cases Per 100000 Population
Colorectal Cancer Rates In Men by Country
Colorectal Cancer Rates In Women by Country
Aging Demographics & Rising Prevalence of Chronic Disorders Enhance Risk of Colorectal Cancer, Necessitating Screening Tests
Global Aging Population: 65+ Individuals by Region for 2019 and 2050
Life Expectancy at Birth and at 65 Age by Region
Launch of Novel Screening Tests for Detection of Inherited Colorectal Cancer to Spur Gene Testing
Market to Benefit from Technological Advancements in Cancer Screening Techniques
R&D Investments in Development of Advanced DNA Sequencing Methods to Drive Market Opportunities
Biomarker Tests for Colorectal Cancer Screening
Molecular Markers Gain Prominence for Colorectal Cancer Screening
Rising Need for Minimally Invasive Colorectal Cancer Screening Tests Drives Demand for Genetic and DNA Biomarkers
At-Home Screening Test for Colorectal Cancer
Government Regulations & Guidelines on Cancer Screening: Potential for Growth
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
A selection of companies mentioned in this report includes
Abbott Laboratories, Inc.
Alere, Inc.
Beckman Coulter, Inc.
Clinical Genomics Technologies Pty Ltd.
Eiken Chemical Co., Ltd.
Epigenomics AG
Exact Sciences Corporation
Hemosure, Inc.
Novigenix SA
Quidel Corporation
Sysmex Corporation
For more information about this report visit https://www.researchandmarkets.com/r/6eo8p6-vitro?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900